BEAM - Beam Therapeutics Inc.
NEXT EARNINGS:
May 12, 2026
EPS Est: $-1.00
|
Rev Est: $12.2M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.33
DETAILS
HIGH:
$74.00
LOW:
$28.00
MEDIAN:
$41.00
CONSENSUS:
$43.33
UPSIDE:
34.19%
Market Cap:
3.28B
Volume:
3,710,460
Avg Volume:
1,793,306
52 Week Range:
13.525-36.44
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.13
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
393
IPO Date:
2020-02-06
EPS (TTM):
-0.81
P/E Ratio:
-34.27
Revenue (TTM):
N/A
Total Assets:
1.48B
Total Debt:
154.12M
Cash & Equiv:
294.94M
Rev Growth (5Y):
412.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $2.33 | $-1.13 | +306.2% | $114.1M | $9.7M | +1076.6% |
| 2025-11-04 | $-1.10 | $-0.98 | -12.2% | $9.7M | $13.2M | -26.6% |
| 2025-08-05 | $-1.00 | $-1.04 | +3.8% | $8.5M | $11.5M | -26.6% |
| 2025-05-06 | $-1.24 | $-1.11 | -11.7% | $7.5M | $15.5M | -51.9% |
| 2025-02-25 | $-1.09 | $-1.25 | +12.8% | $30.1M | $16.5M | +82.5% |
| 2024-11-05 | $-1.17 | $-1.13 | -3.5% | $14.3M | $15.1M | -5.6% |
| 2024-08-06 | $-1.11 | $-1.13 | +1.8% | $11.8M | $13.7M | -14.3% |
| 2024-05-07 | $-1.21 | $-1.45 | +16.6% | $7.4M | $17.0M | -56.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 63.52M | 377.71M | 60.92M | 51.84M | 24,000 | 18,000 | 0 | 0 |
| Net Income | (79.99M) | (376.74M) | (132.53M) | (289.09M) | (370.64M) | (194.59M) | (78.33M) | (115.26M) | (8.73M) |
| EPS | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 | -5.49 | -1.53 | -3.28 | -0.62 |
| Total Assets | 1.48B | 1.10B | 1.46B | 1.34B | 1.47B | 451.68M | 156.10M | 167.01M | 2.40M |
| Total Debt | 154.12M | 161.43M | 172.69M | 179.00M | 147.64M | 107.64M | 31.24M | 0 | 1.01M |
| Cash & Equivalents | 294.94M | 281.97M | 435.89M | 232.77M | 559.99M | 162.17M | 37.22M | 146.44M | 1.90M |
| Operating Cash Flow | (345.10M) | (347.25M) | (149.19M) | 22.53M | (66.27M) | (95.74M) | (72.00M) | (20.30M) | (2.71M) |
| Free Cash Flow | (360.05M) | (356.19M) | (182.93M) | (26.42M) | (113.08M) | (112.10M) | (84.52M) | (33.42M) | (3.05M) |
| FCF per Share | -3.64 | -4.33 | -2.37 | -0.38 | -1.76 | -2.40 | -1.65 | -0.95 | -0.24 |
| Book Value | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M | 245.56M | 100.94M | 134.03M | (4.18M) |
| Cash & ST Investments | 1.25B | 850.74M | 1.19B | 1.08B | 965.65M | 299.67M | 91.85M | 146.44M | 1.90M |
| ROC Equity | -0.06 | -0.51 | -0.14 | -0.39 | -0.45 | -0.79 | -0.78 | -0.86 | N/A |